Conventional treatment
Established treatment components — surgery, radiation, temozolomide, TTFields, supportive care — and options at recurrence. Evidence is separated from regulatory approval, availability and funding.
What is known
Radiation Therapy
Radiation therapy uses high doses of radiation to kill cancer cells and shrink tumors.
Preliminary — not yet clinically reviewed
Claims not yet verified against their sources
Dexamethasone — supportive medication
Dexamethasone is a steroid that reduces brain swelling (edema) around the tumor.
Preliminary — not yet clinically reviewed
Claims not yet verified against their sources
Lomustine (CCNU) — for recurrence
Lomustine is an oral chemotherapy drug considered a treatment option for recurrent glioblastoma after initial treatment.
Preliminary — not yet clinically reviewed
Claims not yet verified against their sources
Surgery (resection or biopsy)
The first surgery for glioblastoma involves removing as much of the tumor as possible (resection) or taking a tissue sample (biopsy) for diagnosis.
Preliminary — not yet clinically reviewed
Claims not yet verified against their sources
Bevacizumab (Avastin) — for recurrence
Bevacizumab is a drug that inhibits new blood vessels the tumor grows (anti-VEGF).
Preliminary — not yet clinically reviewed
Claims not yet verified against their sources
Temozolomide (standard chemotherapy for glioblastoma)
Temozolomide (TMZ) is an oral chemotherapy drug.
Preliminary — not yet clinically reviewed
Claims not yet verified against their sources
Tumor-Treating Fields (TTFields) with Optune
TTFields (Tumor-Treating Fields) is a portable device that delivers alternating electric fields to the tumor region through scalp patches.
Preliminary — not yet clinically reviewed
Claims not yet verified against their sources